Loading company…
Riskpilot
← Back to search
Sign in
Get full access
HaLaCore Pharma AB
AB
Active
Org 5592774235
Läbygatan 17
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2020
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 138K
+2% vs 2023
EBITDA margin
7.6%
-88% vs 2023
Equity ratio
94.1%
Financial strength
Net profit 2024
SEK -212K
+9% vs 2023
EBITDA — year on year
SEK millions
0M
2M
4M
6M
8M
6M
2020
0M
-100%
2021
3M
+300%
2022
0M
-100%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 138K
+2%
EBITDA
SEK 11K
-88%
Net profit
SEK -212K
+9%
Total assets
SEK 1,1M
-53%
Equity
SEK 1,1M
-46%
Employees
0
—
Company information
Legal name
HaLaCore Pharma AB
Org number
5592774235
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
19 oktober 2020
Share capital
SEK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Forsknings och utvecklingsverksamhet samt konsultverksamhet inom life science-branschen samt därmed förenlig verksamhet.
Contact
Address
Läbygatan 17
Email
mlarhed@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Uppsala
All Sweden companies
Revenue
SEK millions
0M
1M
2M
3M
3M
0M
2020
0M
2021
3M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
2M
3M
5M
7M
6M
2020
0M
2021
3M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
282
3 255
135
138
Staff expenses
—
—
—
—
—
EBITDA
6 022
239
3 166
89
11
Depreciation & amort.
−0
−0
—
—
—
EBIT
6 022
239
3 166
89
11
Net financials
—
−670
−310
−323
−222
Profit before tax
6 022
79
—
−233
−212
Tax
−1 289
−122
−659
—
—
Net profit
4 733
−43
2 197
−233
−212
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
9 818
3 736
3 896
2 443
1 139
Equity
4 763
2 320
3 217
1 983
1 072
Long-term debt
0
0
—
—
—
Short-term debt
5 056
1 416
679
460
68
Total debt
5 056
1 416
679
460
68
Financial ratios
5-year trend
EBITDA margin
7.6%
This company
15.8%
Market median
-52% vs market
2020
2024
Equity ratio
94.1%
This company
38.2%
Market median
+146% vs market
2020
2024
Return on equity
-19.8%
This company
18.4%
Market median
-208% vs market
2020
2024
Net profit margin
-153.5%
This company
8.1%
Market median
-1995% vs market
2020
2024
Asset turnover
0.12×
This company
1.12×
Market median
-89% vs market
2020
2024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-10-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
ML
Mats Lars-Erik Larhed
Chief Executive Officer
Chief Executive Officer
2022
—
—
MA
Mathias Anders Hallberg
Deputy Chief Executive Officer
Deputy Chief Executive Officer
2022
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of HaLaCore Pharma AB also hold positions in
0
other companies.
Person
Role here
Other companies
Mats Lars-Erik Larhed
Chief Executive Officer
0 companies
Mathias Anders Hallberg
Deputy Chief Executive Officer
0 companies